SCHEMBL5030892

SCHEMBL5030892

Cc1cc(-c2ccno2)sc1-c1ccc(NC(=O)c2cnns2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.39
RPS6KA3 P51812 1/20 0.36
MAPT P10636 6/20 0.36
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
ATM Q13315 1/20 0.35
GAA P10253 1/20 0.34
GFER P55789 1/20 0.34
ESRRG P62508 1/20 0.34
RXFP1 Q9HBX9 2/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TP53 P04637 1/20 0.34
LRRK2 Q5S007 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5030789 0.81 POLB (0.40) POLBKMT2AMEN1ATMGAA
SCHEMBL14360834 0.80 POLB (0.39) POLBMAPTKMT2AMEN1ATM
SCHEMBL5033820 0.80 LMNA (0.49) POLBMAPTKMT2AMEN1ATM
SCHEMBL2891375 0.80 IL2 (0.46) POLBKMT2AMEN1TP53LMNA
SCHEMBL14360910 0.80 LRRK2 (0.42) POLBMAPTKMT2AMEN1ATM
SCHEMBL14360997 0.79 POLB (0.40) POLBMAPTKMT2AMEN1ATM
SCHEMBL8233130 0.79 ALOX15 (0.46) POLBKMT2AMEN1ATMGAA
SCHEMBL14360818 0.79 POLB (0.51) POLBMAPTKMT2AMEN1GAA
SCHEMBL14361068 0.78 POLB (0.47) POLBMAPTKMT2AMEN1HPGD
SCHEMBL2889603 0.75 KMT2A (0.43) POLBMAPTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1983831-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2008-10-29 EP disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
WO-2007087429-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses NLRP3, CCR1, NLRP1 POLB 4194/4885RPS6KA3 2388/4885MAPT 1355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.